Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease

Cardiovascular Drugs and Therapy

Volumn 10, Issue SUPPL. 2, 1996, Pages 613-615

  Riegger, G A J ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Klinik und Poliklinik fur Innere Medizin II   (Germany)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Coronary artery disease; Gene polymorphism; Renin

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ADRENERGIC SYSTEM; CELL PROLIFERATION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENZYME ACTIVITY; FIBROBLAST; HEART AFTERLOAD; HEART INFARCTION; HEART MUSCLE RELAXATION; HEART VENTRICLE FUNCTION; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOSCLEROSIS; CORONARY DISEASE; HUMANS; HYPERTENSION; MORBIDITY; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 0030473994     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00052507     Document Type: Conference Paper

References (19)

1. Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-449.
2. Aldermann MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
3. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
4. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fraction. Lancet 1992;340:1173-1178.
5. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330: 1041-1046.
6. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
7. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol O, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-1346.
9. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90: 669-676.
10. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin converting enzyme in the human heart: Effects of the deletion/insertion polymorphism. Circulation, in press.
11. Beohar N, Damaraju S, Prather A, et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995;43:275-280.
12. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin-I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
13. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91:2120-2124.
14. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-274.
15. Ruiz J, Blanché H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
16. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995;91: 1655-1658.
17. Lindpainter K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
18. Kingma JH, van Gilst WH, Peels CH, Dambrink JHE, Verheught FWA, Wielenga RP. Acute intervention with captopril during thrombolysis in patients with a first anterior myocardial infarction. Eur Heart J 1994;15:898-907.
19. Pinto YM, van Gilst WH, Kingma H, Schunkert H. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. J Am Coll Cardiol 1995;25: 1622-1626.